Becton Dickinson recalls certain needle set lots used for emergency IV access

• As of June 2026, BD received 75 complaints and 45 reports of serious injury, including four patient deaths during cardiac arrest resuscitation when the obturator could not be removed
• The affected needle sets were manufactured with parts slightly outside normal size specifications and shipped between September 30, 2024, and June 12, 2026
• Inability to remove the obturator may force medical staff to seek alternative IV access methods, potentially causing dangerous delays for critically ill patients

Summary

Becton Dickinson (BD) Recalls Emergency IV Needle Sets Due to Safety Defect

Becton Dickinson announced a U.S. recall of certain lots of intraosseous needle sets used for emergency intravenous access after reports of a critical component malfunction. The devices deliver fluids and medications directly into bone during emergencies when standard IV lines cannot be established quickly enough, typically in cardiac arrest or severe trauma cases.

Key Issue: The obturator (stylet) component sometimes cannot be removed after needle insertion, potentially caused by improper drill withdrawal or incorrect rotation during removal. The affected products were manufactured with parts slightly outside normal size specifications.

Critical Data Points:

• 75 complaints received as of June 2026
• 45 reports of serious injury related to the malfunction
• 4 patient deaths during out-of-hospital cardiac arrest resuscitation when the component could not be removed
• Affected units shipped between September 30, 2024, and June 12, 2026

Clinical Impact: When the obturator fails to detach, medical personnel must obtain replacement equipment or switch to alternative delivery methods like peripheral IV catheters. This delay poses significant risk to critically ill patients requiring immediate intervention.

The recall affects specific needle set lots only; the powered driver tool used for insertion is not included. BD has notified the U.S. Food and Drug Administration of the recall.

Market Implications: This Class I recall (the most serious type) could expose BD to liability claims and regulatory scrutiny, potentially impacting the medical device manufacturer's reputation in emergency care equipment. Healthcare facilities may need to review inventory and establish alternative emergency protocols.